Olema Oncology announces common stock and warrants offering, no amount given

Olema Pharmaceuticals announced its plans to commence a public offering, subject to market and other conditions, to issue and sell shares of its common stock, or for certain investors that so choose, in lieu of shares of common stock, pre-funded warrants to purchase shares of its common stock. All of the securities are being offered by Olema. TD Cowen is acting as book-running manager for the proposed offering.